• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BCL-w:在健康和疾病中的凋亡和非凋亡作用。

BCL-w: apoptotic and non-apoptotic role in health and disease.

机构信息

Department of Molecular Biology of Cancer, Medical University of Lodz, 6/8 Mazowiecka Street, 92-215, Lodz, Poland.

出版信息

Cell Death Dis. 2020 Apr 21;11(4):260. doi: 10.1038/s41419-020-2417-0.

DOI:10.1038/s41419-020-2417-0
PMID:32317622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7174325/
Abstract

The BCL-2 family of proteins integrates signals that trigger either cell survival or apoptosis. The balance between pro-survival and pro-apoptotic proteins is important for tissue development and homeostasis, while impaired apoptosis contributes to several pathologies and can be a barrier against effective treatment. BCL-w is an anti-apoptotic protein that shares a sequence similarity with BCL-X, and exhibits a high conformational flexibility. BCL-w level is controlled by a number of signaling pathways, and the repertoire of transcriptional regulators largely depends on the cellular and developmental context. As only a few disease-relevant genetic alterations of BCL2L2 have been identified, increased levels of BCL-w might be a consequence of abnormal activation of signaling cascades involved in the regulation of BCL-w expression. In addition, BCL-w transcript is a target of a plethora of miRNAs. Besides its originally recognized pro-survival function during spermatogenesis, BCL-w has been envisaged in different types of normal and diseased cells as an anti-apoptotic protein. BCL-w contributes to survival of senescent and drug-resistant cells. Its non-apoptotic role in the promotion of cell migration and invasion has also been elucidated. Growing evidence indicates that a high BCL-w level can be therapeutically relevant in neurodegenerative disorders, neuron dysfunctions and after small intestinal resection, whereas BCL-w inhibition can be beneficial for cancer patients. Although several drugs and natural compounds can bi-directionally affect BCL-w level, agents that selectively target BCL-w are not yet available. This review discusses current knowledge on the role of BCL-w in health, non-cancerous diseases and cancer.

摘要

BCL-2 蛋白家族整合了触发细胞存活或凋亡的信号。促生存和促凋亡蛋白之间的平衡对于组织发育和内稳态很重要,而凋亡受损会导致多种病理,并可能成为有效治疗的障碍。BCL-w 是一种抗凋亡蛋白,与 BCL-X 具有序列相似性,并且表现出高度的构象灵活性。BCL-w 的水平受许多信号通路的控制,转录调节剂的 repertoire 在很大程度上取决于细胞和发育背景。由于仅鉴定出少数与 BCL2L2 相关的疾病相关遗传改变,因此 BCL-w 的水平升高可能是参与 BCL-w 表达调控的信号级联异常激活的结果。此外,BCL-w 转录本是众多 miRNAs 的靶标。除了在精子发生过程中最初被认为具有促生存功能外,BCL-w 还被设想为正常和患病细胞中的抗凋亡蛋白。BCL-w 有助于衰老和耐药细胞的存活。它在促进细胞迁移和侵袭中的非凋亡作用也已阐明。越来越多的证据表明,高 BCL-w 水平在神经退行性疾病、神经元功能障碍和小肠切除后可能具有治疗相关性,而 BCL-w 抑制对癌症患者可能有益。尽管几种药物和天然化合物可以双向影响 BCL-w 水平,但尚未有专门针对 BCL-w 的药物。本文综述了 BCL-w 在健康、非癌症疾病和癌症中的作用的最新知识。

相似文献

1
BCL-w: apoptotic and non-apoptotic role in health and disease.BCL-w:在健康和疾病中的凋亡和非凋亡作用。
Cell Death Dis. 2020 Apr 21;11(4):260. doi: 10.1038/s41419-020-2417-0.
2
Bcl-xL: A Focus on Melanoma Pathobiology.Bcl-xL:聚焦黑色素瘤病理生物学。
Int J Mol Sci. 2021 Mar 9;22(5):2777. doi: 10.3390/ijms22052777.
3
BCL-2 family isoforms in apoptosis and cancer.BCL-2 家族在细胞凋亡和癌症中的亚型。
Cell Death Dis. 2019 Feb 21;10(3):177. doi: 10.1038/s41419-019-1407-6.
4
Src and epidermal growth factor receptor mediate the pro-invasive activity of Bcl-w.Src和表皮生长因子受体介导Bcl-w的促侵袭活性。
Tumour Biol. 2016 Jan;37(1):1245-52. doi: 10.1007/s13277-015-3917-x. Epub 2015 Aug 20.
5
Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors.一种新型衰老细胞溶解剂——navitoclax的鉴定,其作用靶点为抗凋亡因子Bcl-2家族。
Aging Cell. 2016 Jun;15(3):428-35. doi: 10.1111/acel.12445. Epub 2016 Mar 18.
6
Secretin Prevents Apoptosis in the Developing Cerebellum Through Bcl-2 and Bcl-xL.缩胆囊素通过 Bcl-2 和 Bcl-xL 防止发育中的小脑细胞凋亡。
J Mol Neurosci. 2019 Jul;68(3):494-503. doi: 10.1007/s12031-019-01287-y. Epub 2019 Mar 14.
7
In non-transformed cells Bak activates upon loss of anti-apoptotic Bcl-XL and Mcl-1 but in the absence of active BH3-only proteins.在未转化的细胞中,Bak在抗凋亡蛋白Bcl-XL和Mcl-1缺失时激活,但前提是不存在活性的仅含BH3结构域的蛋白。
Cell Death Dis. 2015 Nov 26;6(11):e1996. doi: 10.1038/cddis.2015.341.
8
Extra-mitochondrial prosurvival BCL-2 proteins regulate gene transcription by inhibiting the SUFU tumour suppressor.线粒体外促生存BCL-2蛋白通过抑制肿瘤抑制因子SUFU来调节基因转录。
Nat Cell Biol. 2017 Oct;19(10):1226-1236. doi: 10.1038/ncb3616. Epub 2017 Sep 25.
9
NF-κB activation fails to protect cells to TNFα-induced apoptosis in the absence of Bcl-xL, but not Mcl-1, Bcl-2 or Bcl-w.在缺乏Bcl-xL而非Mcl-1、Bcl-2或Bcl-w的情况下,NF-κB激活无法保护细胞免受TNFα诱导的凋亡。
Biochim Biophys Acta. 2013 May;1833(5):1085-95. doi: 10.1016/j.bbamcr.2013.01.014. Epub 2013 Jan 28.
10
Molecular dynamic simulations on an inhibitor of anti-apoptotic Bcl-2 proteins for insights into its interaction mechanism for anti-cancer activity.抗凋亡 Bcl-2 蛋白抑制剂的分子动力学模拟研究及其抗癌活性的相互作用机制。
J Biomol Struct Dyn. 2019 Aug;37(12):3109-3121. doi: 10.1080/07391102.2018.1508371. Epub 2018 Dec 10.

引用本文的文献

1
A new era in cancer therapy: targeting the Proteasome-Bcl-2 axis.癌症治疗的新时代:靶向蛋白酶体 - Bcl - 2轴。
J Exp Clin Cancer Res. 2025 Aug 21;44(1):246. doi: 10.1186/s13046-025-03505-5.
2
Ameliorative Role of Phosphodiesterase-5 (PDE-5) Inhibitor "Avanafil" via Modulating cAMP & cGMP Pathway Against Alzheimer's Disease.磷酸二酯酶-5(PDE-5)抑制剂“阿伐那非”通过调节环磷酸腺苷(cAMP)和环磷酸鸟苷(cGMP)途径对阿尔茨海默病的改善作用
Neurochem Res. 2025 Aug 13;50(4):258. doi: 10.1007/s11064-025-04516-6.
3
Variable roles of miRNA- and apoptosis-linked genes in invasive breast cancer: expression patterns, clinicopathological associations, and prognostic significance.

本文引用的文献

1
Inhibition of BCL2 Family Members Increases the Efficacy of Copper Chelation in BRAF-Driven Melanoma.抑制 BCL2 家族成员可提高 BRAF 驱动的黑色素瘤中铜螯合物的疗效。
Cancer Res. 2020 Apr 1;80(7):1387-1400. doi: 10.1158/0008-5472.CAN-19-1784. Epub 2020 Jan 31.
2
BCL-W is dispensable for the sustained survival of select Burkitt lymphoma and diffuse large B-cell lymphoma cell lines.BCL-W 对于某些 Burkitt 淋巴瘤和弥漫性大 B 细胞淋巴瘤细胞系的持续存活是可有可无的。
Blood Adv. 2020 Jan 28;4(2):356-366. doi: 10.1182/bloodadvances.2019000541.
3
LncRNA RMST-mediated miR-107 transcription promotes OGD-induced neuronal apoptosis via interacting with hnRNPK.
miRNA与凋亡相关基因在浸润性乳腺癌中的可变作用:表达模式、临床病理关联及预后意义
Mol Biol Rep. 2025 Jul 11;52(1):703. doi: 10.1007/s11033-025-10739-1.
4
Amentoflavone Impedes NF-κB Activation and Mediates Apoptosis Induction in Lung Cancer Cells: An in vitro and in silico exploration.穗花杉双黄酮抑制肺癌细胞中NF-κB的激活并介导细胞凋亡诱导:一项体外和计算机模拟研究
J Inflamm Res. 2025 Jul 1;18:8657-8673. doi: 10.2147/JIR.S521756. eCollection 2025.
5
Baicalein-mediated regulation of Nrf2/ARE, NFĸB, and MAPK signaling in Huntington's disease: a promising strategy against neuroinflammation and neurodegeneration.黄芩素介导的对亨廷顿舞蹈病中Nrf2/ARE、NFκB和MAPK信号通路的调控:一种对抗神经炎症和神经退行性变的有前景的策略。
Inflammopharmacology. 2025 Jul 5. doi: 10.1007/s10787-025-01839-2.
6
The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy.BCL2家族:从细胞凋亡机制到靶向治疗的新进展
Signal Transduct Target Ther. 2025 Mar 21;10(1):91. doi: 10.1038/s41392-025-02176-0.
7
Onvansertib and Navitoclax Combination as a New Therapeutic Option for Mucinous Ovarian Carcinoma.奥万塞替布与纳维托克司联合用药作为黏液性卵巢癌的一种新治疗选择
Int J Mol Sci. 2025 Jan 8;26(2):472. doi: 10.3390/ijms26020472.
8
Divergent paths of mammary gland involution: unveiling the cellular dynamics in abruptly and gradually involuted mouse models.乳腺退化的不同路径:揭示突然和逐渐退化的小鼠模型中的细胞动力学
Breast Cancer Res. 2025 Jan 3;27(1):1. doi: 10.1186/s13058-024-01933-3.
9
Dissecting the neuroprotective interaction between the BH4 domain of BCL-w and the IP3 receptor.解析 BCL-w 的 BH4 结构域与 IP3 受体之间的神经保护相互作用。
Cell Chem Biol. 2024 Oct 17;31(10):1815-1826.e5. doi: 10.1016/j.chembiol.2024.06.016. Epub 2024 Jul 26.
10
Carbazole Derivatives Binding to Bcl-2 Promoter Sequence G-quadruplex.咔唑衍生物与Bcl-2启动子序列G-四链体的结合
Pharmaceuticals (Basel). 2024 Jul 9;17(7):912. doi: 10.3390/ph17070912.
长链非编码 RNA RMST 通过与 hnRNPK 相互作用促进 OGD 诱导的神经元细胞凋亡的 miR-107 转录。
Neurochem Int. 2020 Feb;133:104644. doi: 10.1016/j.neuint.2019.104644. Epub 2019 Dec 15.
4
Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian Cancer.基于基因组的联合筛选鉴定出抗凋亡基因,其可作为卵巢癌化疗耐药的靶向治疗新靶点。
Mol Cancer Res. 2019 Nov;17(11):2281-2293. doi: 10.1158/1541-7786.MCR-18-1243. Epub 2019 Aug 28.
5
miRNA-125a-5p inhibits hepatocellular carcinoma cell proliferation and induces apoptosis by targeting TP53 regulated inhibitor of apoptosis 1 and Bcl-2-like-2 protein.微小RNA-125a-5p通过靶向TP53调控的凋亡抑制因子1和Bcl-2样蛋白2抑制肝癌细胞增殖并诱导凋亡。
Exp Ther Med. 2019 Aug;18(2):1196-1202. doi: 10.3892/etm.2019.7674. Epub 2019 Jun 14.
6
miR-340-5p Suppresses Aggressiveness in Glioblastoma Multiforme by Targeting Bcl-w and Sox2.miR-340-5p通过靶向Bcl-w和Sox2抑制多形性胶质母细胞瘤的侵袭性。
Mol Ther Nucleic Acids. 2019 Sep 6;17:245-255. doi: 10.1016/j.omtn.2019.05.022. Epub 2019 Jun 5.
7
The Structural Biology of Bcl-x.Bcl-x 的结构生物学
Int J Mol Sci. 2019 May 7;20(9):2234. doi: 10.3390/ijms20092234.
8
The landscape of chimeric RNAs in bladder urothelial carcinoma.膀胱癌中嵌合 RNA 的研究现状。
Int J Biochem Cell Biol. 2019 May;110:50-58. doi: 10.1016/j.biocel.2019.02.007. Epub 2019 Feb 25.
9
BCL-2 family isoforms in apoptosis and cancer.BCL-2 家族在细胞凋亡和癌症中的亚型。
Cell Death Dis. 2019 Feb 21;10(3):177. doi: 10.1038/s41419-019-1407-6.
10
Hypermethylation of miR-205-5p by IR Governs Aggressiveness and Metastasis via Regulating Bcl-w and Src.辐射诱导的miR-205-5p高甲基化通过调控Bcl-w和Src决定侵袭性和转移能力。
Mol Ther Nucleic Acids. 2019 Mar 1;14:450-464. doi: 10.1016/j.omtn.2018.12.013. Epub 2018 Dec 31.